INVESTMENT AGREEMENT dated as of January 4, 2019 by and among AGILON HEALTH TOPCO, INC. as the Company and EACH ENTITY LISTED ON EXHIBIT A HERETO as a PurchaserInvestment Agreement • March 18th, 2021 • Agilon Health, Inc. • Services-misc health & allied services, nec • New York
Contract Type FiledMarch 18th, 2021 Company Industry JurisdictionThis Investment Agreement, dated as of January 4, 2019 (as amended, restated, supplemented or otherwise modified from time to time in accordance with the terms hereof, this “Agreement”), is by and among Agilon Health Topco, Inc., a Delaware corporation (the “Company”), and each entity listed on Exhibit A attached hereto, as amended from time to time, severally and not jointly (each, a “Purchaser”). The Company and each Purchaser are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
INVESTMENT AGREEMENT dated as of November 7, 2018 by and among AGILON HEALTH TOPCO, INC. as the Company and EACH ENTITY LISTED ON EXHIBIT A HERETO as a PurchaserInvestment Agreement • March 18th, 2021 • Agilon Health, Inc. • Services-misc health & allied services, nec • New York
Contract Type FiledMarch 18th, 2021 Company Industry JurisdictionThis Investment Agreement, dated as of November 7, 2018 (as amended, restated, supplemented or otherwise modified from time to time in accordance with the terms hereof, this “Agreement”), is by and among Agilon Health Topco, Inc., a Delaware corporation (the “Company”), and each entity listed on Exhibit A attached hereto, as amended from time to time, severally and not jointly (each, a “Purchaser”), acting by and through one of Morgan Stanley Investment Management Inc. or Morgan Stanley Investment Management Ltd., as agent and investment adviser to Purchasers (each, an “Agent”). The Company and each Purchaser are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.